Replies to post #269279 on Amarin Corp Plc (AMRN)

[dukesking]

Circuitcity, KDPharma has to show success in treating FAP first. Not an easy disease to treat or cure and at 2 grams a day in their phase 3 trial it will be a long shot IMO. AMRN is also in a trial to treat colon cancer(s) so we may have some protection if successful. It does show that all these delays for Amarin is allowing competitors time to find ways to catch up and find ways to get in on AMRN’s proven CVD market. Look how much has been done to slow AMRN’s success and CVD launch since Sept 24th. I hope I’m completely wrong in my assumptions.

[Restingzebra]

And management fiddles while Rome burns? WTF?